Meeder Asset Management Inc Cytom X Therapeutics, Inc. Transaction History

Meeder Asset Management Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 08, 2021	SELL	$4.32 - $6.43 $397 - $591	-92 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$6.33 - $9.91 $34,327 - $53,741	-5,423 Reduced 98.33%	92 $1,000
Q1 2021 Apr 28, 2021	BUY	$6.6 - $9.0 $36,399 - $49,635	5,515 New	5,515 $43,000
Q3 2020 Nov 02, 2020	SELL	$6.55 - $8.83 $20,684 - $27,885	-3,158 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$7.4 - $14.64 $35,394 - $70,023	-4,783 Reduced 60.23%	3,158 $26,000
Q1 2020 May 15, 2020	BUY	$3.61 - $8.6 $16,374 - $39,009	4,536 Added 133.22%	7,941 $60,000
Q4 2019 Feb 13, 2020	BUY	$5.17 - $8.91 $17,603 - $30,338	3,405 New	3,405 $28,000
Q3 2019 Oct 17, 2019	SELL	$7.38 - $12.25 $10,560 - $17,529	-1,431 Closed	0 $0
Q2 2019 Aug 05, 2019	BUY	$9.35 - $11.41 $9,611 - $11,729	1,028 Added 255.09%	1,431 $16,000
Q1 2019 Apr 16, 2019	BUY	$9.5 - $19.16 $3,828 - $7,721	403 New	403 $4,000
Q4 2018 Jan 17, 2019	SELL	$12.69 - $18.61 $22,385 - $32,828	-1,764 Closed	0 $0
Q3 2018 Nov 02, 2018	SELL	$18.04 - $26.41 $12,068 - $17,668	-669 Reduced 27.5%	1,764 $0
Q2 2018 Jul 24, 2018	BUY	$21.38 - $29.68 $19,477 - $27,038	911 Added 59.86%	2,433 $0
Q1 2018 May 03, 2018	BUY	$21.76 - $34.22 $16,951 - $26,657	779 Added 104.85%	1,522 $44,000
Q4 2017 Feb 02, 2018	BUY	$19.0 - $23.09 $608 - $738	32 Added 4.5%	743 $16,000
Q3 2017 Oct 20, 2017	BUY	$13.53 - $18.17 $9,619 - $12,918	711	711 $13,000

49.4M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $55.4M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.